NEXGEL, Inc. (NASDAQ:NXGLW) Sees Large Decline in Short Interest

NEXGEL, Inc. (NASDAQ:NXGLW) saw a significant decline in short interest in February. As of February 13th, there was short interest totaling 1,095 shares, a decline of 32.4% from the January 29th total of 1,621 shares. Based on an average daily volume of 4,049 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 4,049 shares, the short-interest ratio is presently 0.3 days.

NEXGEL Stock Up 1.0%

Shares of NASDAQ:NXGLW traded up $0.00 during mid-day trading on Monday, reaching $0.15. 928 shares of the stock were exchanged, compared to its average volume of 3,275. The stock’s 50 day simple moving average is $0.18 and its 200-day simple moving average is $0.24. NEXGEL has a one year low of $0.10 and a one year high of $0.64.

NEXGEL Company Profile

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.